surmount 2 tirzepatide SURMOUNT-2: achieved up to 15.7% weight loss SURMOUNT‐1 study design. This is

Why You Need This Bundle: Prevent loose skin during rapid weight loss

Digestive Issues Diarrhea and constipation both occur with semaglutide, sometimes alternating in the same person at different times

Therefore, given the association with improved nutritional status under semaglutide treatment, this GLP-1RA could be explored in other obesity-related conditions, including fatty liver disease, dyslipidemia, hypertension, and potentially even cancer

59 Compared to human GLP-1 (Figure 1A), the alanine residue at the second position of the N-terminus in GLP-1 RAs and a dual GLP-1/GIP RA (except for liraglutide) has been substituted to prevent metabolism by DPP-4 (Figure 1)

Nonetheless thanks to their unique mechanisms both Compound Semaglugtides & Wegovy may serve as optimal treatments especially for individuals who have struggled with traditional diet & exercise regimes but also need careful management of their glucose levels due their diabetic condition